Skip to Content

Russell Inv Equity Income S RLISX

Medalist Rating as of | See Russell Investments Investment Hub
  • NAV / 1-Day Return 24.34  /  +0.21 %
  • Total Assets 190.2 Mil
  • Adj. Expense Ratio
    0.650%
  • Expense Ratio 0.830%
  • Distribution Fee Level Below Average
  • Share Class Type No Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment
  • Status Open
  • TTM Yield 1.65%
  • Turnover 31%

USD | NAV as of Feb 23, 2024 | 1-Day Return as of Feb 23, 2024, 11:18 PM GMT+0

Morningstar’s Analysis RLISX

Will RLISX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Weakness in Russell Inv Equity Income S's People and Process Pillar ratings limits this strategy to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings RLISX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 20.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

E-mini S&P 500 Future Mar 24

4.62 9.0 Mil

U.S. Cash Management Fund

4.54 8.8 Mil
Cash and Equivalents

CVS Health Corp

2.17 4.2 Mil
Healthcare

JPMorgan Chase & Co

2.14 4.2 Mil
Financial Services

Berkshire Hathaway Inc Class B

1.95 3.8 Mil
Financial Services

Johnson & Johnson

1.76 3.4 Mil
Healthcare

Wells Fargo & Co

1.61 3.1 Mil
Financial Services

Allstate Corp

1.57 3.1 Mil
Financial Services

Merck & Co Inc

1.56 3.0 Mil
Healthcare

Citigroup Inc

1.49 2.9 Mil
Financial Services